Vishay Intertechnology Insider Sold Shares Worth $597,096, According to a Recent SEC Filing-September 2024-www.financetom.com

Vishay Intertechnology Insider Sold Shares Worth $597,096, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Vishay Intertechnology Insider Sold Shares Worth $597,096, According to a Recent SEC Filing

Mar 6, 2024 6:29 AM

09:07 AM EST, 03/06/2024 (MT Newswires) -- Marc Zandman, Director, ExecChairman & Chief Bus Dev, on March 04, 2024, sold 26,154 shares in Vishay Intertechnology ( VSH ) for $597,096. Following the Form 4 filing with the SEC, Zandman has control over a total of 73,678 shares of the company, with 73,678 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/103730/000010373024000059/xslF345X03/form4.xml

Previous page： Lilly's Foundayo hits 1,390 prescriptions in debut week Next page： Lilly's obesity pill Foundayo gets 1,390 prescriptions in debut week

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Lilly's Foundayo hits 1,390 prescriptions in debut week

Apr 17, 2026

April 17 (Reuters) - Eli Lilly's ( LLY ) newly launched obesity pill was prescribed 1,390 times in the U.S. as of the week ended April 10, according to an analyst who cited IQVIA data. Novo Nordisk's oral Wegovy had hit 3,071 U.S. prescriptions in the first four days after its launch on January 5. ...

Lilly's obesity pill Foundayo gets 1,390 prescriptions in debut week

Apr 17, 2026

Market Chatter: Silgan's Bid to Acquire Gerresheimer Rejected

Apr 17, 2026

06:54 AM EDT, 04/17/2026 (MT Newswires) -- Silgan's ( SLGN ) bid to take over German medical packaging maker Gerresheimer has been rejected, Reuters reported Friday, citing sources familiar with the matter. Talks between the two companies have concluded, the sources reportedly said. Silgan ( SLGN ) made a non-binding offer of 41 euros ($48.36) per share, Reuters previously reported....

Bruker's Division Rolls Out MyGenius PRO Diagnostics System in Europe

Apr 17, 2026

06:53 AM EDT, 04/17/2026 (MT Newswires) -- Bruker's ( BRKR ) Bruker Microbiology & Infection Diagnostics division said Friday it has rolled out molecular diagnostics system MyGenius PRO in Europe. The new diagnostics system is based on polymerase chain reaction, developed to diagnose infectious diseases, according to the division. Bruker Microbiology said the MyGenius PRO system automates the complete workflow...